Radius: Radius Pharma grants Pharmanovia the exclusive commercialization rights to abaloparatide in China and selected Asia Pacific territories
Radius Pharmaceuticals, Inc., a wholly owned subsidiary of Radius Health, Inc., a specialty biopharmaceutical company focused on bone health and related areas, announced that it has granted Pharmanovia the exclusive
Read full article »
President & CEO
Kelly Martin
Radius is a Massachusetts-based biotechnology company that develops and commercializes novel therapeutics for the treatment of osteoporosis, cancer, and endocrine diseases.
Read more